PharmaMar is one of Spain’s leading pharmaceutical companies in terms of investment in research, development and innovation. PharmaMar has invested nearly 600 million euros in R&D&I since its foundation.
Founded in 1986 and part of the Zeltia Group, it is a biopharmaceutical company determined to advance cancer treatment through the discovery, development, production and marketing of innovative marine-derived drugs.
The company has a unique sample of marine organisms consisting of more than 165,000 specimens. PharmaMar’s Research, Development and Innovation department has discovered 700 new chemical entities and identified 30 new families of compounds. PharmaMar’s facilities are used to synthesise intermediates and active ingredients for the manufacture of medicines, as well as secondary packaging to meet the needs of our ongoing Clinical Trials products and Compassionate Use programmes.
Sistrol has collaborated in different areas, from the implementation of the BMS, engineering and its start-up, to various actions for its pressure probes, cooled water, acs, distributed control for electromechanical installations, electrical lines and panels, actions on speed variators, impulsion probes, thermostats, and adjustment of laboratory room pressures.